Is food noise an eating disorder?

No. Food noise is a descriptive term, not a diagnosis, and it does not appear in the DSM-5. It can overlap with symptoms seen in binge eating disorder and other conditions, so a clinician should assess persistent, distressing preoccupation with food rather than assuming it is just food noise.

Can you have food noise without having obesity?

Yes. The Food Noise Questionnaire was validated in a general adult sample, not only in people with obesity. Intrusive thoughts about food are reported across a wide range of body sizes, though most research so far has been done in weight management settings.

Do all GLP-1 medications affect food noise the same way?

The published craving and control-of-eating data are strongest for semaglutide 2.4 mg from the STEP program. Other agents work on the same receptor, and tirzepatide adds a GIP receptor effect, but head-to-head food noise comparisons have not been published.

How fast does food noise quiet down after starting a GLP-1 drug?

The European Congress on Obesity presentation measured a change over roughly one month, and STEP 5 saw craving improvements by week 20. Timing varies by person and by dose escalation schedule, so there is no single expected timeline.

Can lifestyle changes reduce food noise without medication?

The Pennington analysis found that behavioral treatment alone did lower Food Noise Questionnaire scores, just by a smaller amount than behavioral treatment plus a GLP-1 drug. Sleep, stress, and structured eating patterns all influence food cue reactivity in the broader literature.

What Is 'Food Noise' And Why Do GLP-1 Drugs Quiet It?

The short answer: "Food noise" is the popular name for persistent, intrusive thoughts about food that crowd out everything else. It is not a formal diagnosis, but researchers now measure it with a validated five-item questionnaire. GLP-1 drugs appear to quiet it because GLP-1 receptors sit in brain regions that regulate appetite and reward. Activating those receptors lowers the brain's response to food cues and reduces reported cravings.

What exactly is food noise?

Food noise started as a patient word, not a clinical one. People taking GLP-1 medications used it to describe a constant mental commentary about eating: what to eat next, what is in the kitchen, how long until the next meal.

The first serious academic attempt to define it appeared in 2023. In a paper in Nutrients, Hayashi and colleagues defined food noise as "heightened and/or persistent manifestations of food cue reactivity, often leading to food-related intrusive thoughts and maladaptive eating behaviors."

That paper also proposed a framework called the CIRO model. It maps food cue reactivity across four parts: the cue, the influencers (things like genetics and stress), the reactivity itself, and the outcome. The authors noted that patient reports of less "rumination and obsessive preoccupation about food" on semaglutide were what prompted the work.

A 2026 narrative review in Cureus described food noise as persistent thoughts about food that the person experiences as unwanted or distressing. The common thread across definitions is intrusiveness. Ordinary hunger goes away when you eat. Food noise, as patients describe it, does not.

How do researchers measure food noise?

Until recently, nobody could measure it. That changed in 2025 with the Food Noise Questionnaire (FNQ), published in Obesity by Diktas and colleagues at Pennington Biomedical Research Center.

The FNQ is short and simple:

Five items, each rated from 0 to 4 on an agree/disagree scale.
A total score from 0 to 20, where higher means more food noise.
Items such as "I find myself constantly thinking about food" and "My thoughts about food distract me from what I need to do."

In the validation study, 400 people completed the questionnaire and data from 396 were analyzed. Internal consistency was excellent (Cronbach alpha 0.93) and seven-day test-retest reliability was high (r = 0.79). All five items loaded onto a single factor. Several co-authors were employees or shareholders of WW International, which the paper disclosed.

An Italian-language version was validated separately and published in Behavioral Sciences in 2026, with similar single-factor results. So food noise now has a measuring tool. It still does not have a diagnostic code.

Why do GLP-1 drugs quiet food noise?

The mechanism is central, not just digestive. The FDA-approved label for Wegovy (semaglutide) states that GLP-1 "is a physiological regulator of appetite and caloric intake, and the GLP-1 receptor is present in several areas of the brain involved in appetite regulation." The label adds that animal studies show semaglutide reaching and activating neurons in brain regions that control food intake.

The National Institute of Diabetes and Digestive and Kidney Diseases puts it plainly: these drugs mimic a hormone that "targets areas of the brain that regulate appetite and food intake."

Natural GLP-1 comes from cells in the gut after you eat. A 2024 review in the Journal of Physiological Sciences describes how gut satiety signals, including GLP-1, reach the brain through the vagus nerve and the hypothalamus. Medications extend that signal far beyond its normal minutes-long lifespan.

Brain imaging supports the reward angle. In a randomized crossover trial published in Diabetes in 2014, 48 lean, obese, and type 2 diabetes participants viewed food pictures during functional MRI. The GLP-1 receptor agonist exenatide reduced food intake and reduced food-cue responses in the insula, amygdala, putamen, and orbitofrontal cortex. Blocking the GLP-1 receptor first largely erased those effects. That is a direct link between the receptor and the brain's reaction to food cues. For more on the underlying pathway, see our guide to how GLP-1 drugs work.

What does the trial evidence show?

Most large trials did not measure "food noise" by name. They measured cravings and control of eating, which overlap heavily with it.

In the STEP 5 analysis published in Obesity in 2023, a subgroup completed a 19-item Control of Eating Questionnaire at weeks 0, 20, 52, and 104. Among those participants (semaglutide n = 88, placebo n = 86), mean body weight change was -14.8% with semaglutide 2.4 mg and -2.4% with placebo. Craving Control and Craving for Savory scores improved significantly versus placebo at weeks 20, 52, and 104 (p < 0.01). At 104 weeks, difficulty resisting cravings and control of eating were also significantly better with semaglutide.

The first study to use the food noise measure directly was presented at the 33rd European Congress on Obesity in May 2026. Pennington Biomedical reported that among 417 adults in a digital weight management program, the group starting a GLP-1 drug (n = 92) had an adjusted mean FNQ drop of 4.05 points. The behavioral-only group (n = 325) dropped 1.15 points, a between-group difference of 3.0 points over about one month. Treat that carefully: it is a conference presentation and a non-randomized comparison, not a peer-reviewed randomized trial.

Does quieter food noise mean more weight loss?

The two travel together, but the direction of cause is not settled. In STEP 5, improvements in craving scores were positively correlated with weight reduction from baseline to week 104. A correlation is not proof that one caused the other.

People also report that the quiet is not permanent at a fixed level. Appetite effects can feel strongest early and less dramatic later, which is one reason progress can stall. We cover that pattern separately in why weight loss plateaus on GLP-1 drugs. If you want drug-specific detail on semaglutide, ozempic.md tracks that molecule on its own.

Does food noise come back after stopping?

No trial has measured FNQ scores after withdrawal. What we do know is that the weight effect reverses. In the STEP 1 trial extension published in Diabetes, Obesity and Metabolism in 2022, 327 participants were followed for a year after treatment stopped. Semaglutide participants had lost 17.3% of body weight at week 68. They regained 11.6 percentage points of that loss by week 120, roughly two-thirds.

The authors concluded that ongoing treatment is required to maintain the improvements. Since the appetite signal depends on the drug being present, it is reasonable to expect food-related thoughts to return as the drug clears. Many patients describe exactly that. For the broader picture, read what happens when you stop taking GLP-1 drugs.

The bottom line

Food noise is real enough to measure, even though it is not a diagnosis. It means intrusive, repetitive thinking about food that interferes with daily life. GLP-1 receptors sit in appetite and reward regions of the brain, and activating them lowers the brain's reaction to food cues, which is the most likely reason the noise fades.

The strongest published evidence is indirect: craving and control-of-eating scores improved significantly on semaglutide in STEP 5, and imaging shows reduced food-cue responses. Direct food noise data exists but is early. If constant thoughts about food are affecting your daily function, that is worth raising with a clinician, medication or not.

Last updated: September 2026. This article is for informational purposes only and does not constitute medical advice. Talk with a licensed clinician before starting, changing, or stopping any GLP-1 medication, and seek professional help if intrusive thoughts about food are causing distress.